M.D. Sass Fully Exits SLM Corporation Holdings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Fool
- Institutional Exit Analysis: M.D. Sass sold 1,399,804 shares of SLM Corporation in Q1 2026 for approximately $33.1 million, marking a complete exit that reduced its stake from 3% to 0%, indicating a pessimistic outlook on the stock's future performance.
- Financial Performance Comparison: Despite SLM achieving a diluted EPS of $1.54 in Q1 2026, a 10% increase year-over-year, and raising its full-year guidance to $3.10 to $3.20 per share, its stock price has declined about 29% over the past year, significantly underperforming the S&P 500.
- Market Reaction and Investor Confidence: The complete exit by M.D. Sass contrasts sharply with SLM's solid financial results, potentially reflecting concerns over uncertainties in future student loan policies and long-term enrollment trends, leading to diminished confidence among institutional investors.
- Long-Term Investment Perspective: While institutional selling may raise market concerns, SLM remains the largest provider of private student loans in the U.S., suggesting long-term growth potential; investors might consider diversifying risk through related ETFs to gain broader exposure to the consumer finance sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SLM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SLM
Wall Street analysts forecast SLM stock price to rise
11 Analyst Rating
7 Buy
2 Hold
2 Sell
Moderate Buy
Current: 22.390
Low
23.00
Averages
31.09
High
37.00
Current: 22.390
Low
23.00
Averages
31.09
High
37.00
About SLM
SLM Corporation is a holding company, which operates through various subsidiaries and is a financial brand for higher education. The Company’s primary business is to originate and service loans it makes to students and their families to finance the cost of their education. It also offers a range of deposit products insured by the Federal Deposit Insurance Corporation. Its primary private education loan product is the Smart Option Student Loan, which emphasizes in-school payment features that can produce shorter terms and reduce customers’ total finance charges. The Smart Option Student Loan generally runs for six months after the borrower separates from school but can run for up to 36 months for a small subset of graduate loans. It also offers six loan products for specific graduate programs of study. These include the Sallie Mae Law School Loan, the Sallie Mae MBA Loan, the Sallie Mae Graduate School Loan for Health Professions, the Sallie Mae Medical School Loan, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Large Transaction Details: M.D. Sass sold 1,399,804 shares of SLM in Q1 2026, with an estimated transaction value of $33.1 million, marking a complete exit from a position that previously accounted for about 3% of its assets under management.
- Performance Comparison: Despite SLM's diluted earnings per share rising to $1.54 in Q1 2026 from $1.40 a year earlier, and a 5% increase in private education loan originations, the stock has declined approximately 29% over the past year, significantly underperforming the S&P 500.
- Market Reaction Analysis: The complete exit by M.D. Sass highlights a disconnect with SLM's recent performance, as the company raised its full-year earnings guidance to a range of $3.10 to $3.20 per share, yet analysts project modest declines in earnings due to uncertainties surrounding federal student loan policies and long-term enrollment trends.
- Investor Caution: While institutional selling may raise concerns, SLM remains the largest provider of private student loans in the U.S., and for investors who believe in the long-term demand for higher education financing, the current sell-off may warrant closer examination.
See More
- Institutional Exit Analysis: M.D. Sass sold 1,399,804 shares of SLM Corporation in Q1 2026 for approximately $33.1 million, marking a complete exit that reduced its stake from 3% to 0%, indicating a pessimistic outlook on the stock's future performance.
- Financial Performance Comparison: Despite SLM achieving a diluted EPS of $1.54 in Q1 2026, a 10% increase year-over-year, and raising its full-year guidance to $3.10 to $3.20 per share, its stock price has declined about 29% over the past year, significantly underperforming the S&P 500.
- Market Reaction and Investor Confidence: The complete exit by M.D. Sass contrasts sharply with SLM's solid financial results, potentially reflecting concerns over uncertainties in future student loan policies and long-term enrollment trends, leading to diminished confidence among institutional investors.
- Long-Term Investment Perspective: While institutional selling may raise market concerns, SLM remains the largest provider of private student loans in the U.S., suggesting long-term growth potential; investors might consider diversifying risk through related ETFs to gain broader exposure to the consumer finance sector.
See More
- Increased Scholarship Availability: The Sallie Mae Fund has doubled the number of Bridging the Dream Scholarships from 10 to 20, each worth up to $10,000, aimed at assisting more students in completing their graduate studies, particularly in fields like nursing, law, and education.
- Clear Eligibility Criteria: Applicants must be enrolled in or accepted to an accredited graduate or professional degree program, demonstrate financial need, and show a commitment to positively impacting their communities, ensuring that the scholarships assist those who truly need support.
- Community Impact: Since 2021, the Sallie Mae Fund has awarded nearly $5 million in scholarships to help students navigate unplanned expenses and complete their higher education, reflecting its commitment to educational equity and community support.
- Future Outlook: The scholarship application window will remain open until July 17, 2026, and the Sallie Mae Fund also offers various tools and resources to help families plan and pay for college, further promoting equal access to educational opportunities.
See More
- Increased Scholarship Availability: The Sallie Mae Fund is doubling its Bridging the Dream Graduate Scholarship to 20 scholarships, each worth up to $10,000, aimed at assisting more students in completing their graduate studies in critical fields such as nursing, law, and education.
- Clear Eligibility Criteria: Eligible applicants must be enrolled in or accepted to an accredited graduate program, demonstrate financial need, and show a commitment to positively impacting their communities, ensuring effective allocation of scholarships aligned with social responsibility.
- Support for Student Success: Since 2021, the Sallie Mae Fund has awarded nearly $5 million in scholarships to help students navigate unexpected expenses and complete their higher education, demonstrating its ongoing commitment and influence in the educational funding sector.
- Positive Future Outlook: The Sallie Mae Fund is also offering 50 Completing the Dream Scholarships, each up to $2,500, to support students on track to complete their programs during the 2026-2027 academic year, further promoting educational equity and opportunity access.
See More
- Executive Speaking Engagement: Sallie Mae's Co-President and CFO Pete Graham is scheduled to speak at the 2026 Morgan Stanley US Financials Conference on June 10 at 7:30 a.m. ET, highlighting the company's leadership in education financing.
- Investor Communication Channels: The conference will feature a live audio webcast and replay available at SallieMae.com/investors, enhancing investor engagement and transparency.
- Mission in Education Financing: Sallie Mae is committed to supporting access to education and lifelong learning through private student lending, helping customers achieve success both during and after college.
- Company Background Information: Commonly known as Sallie Mae, SLM Corporation and its subsidiaries are not sponsored by or agencies of the United States, emphasizing its independence and market positioning.
See More
- Stock Price Decline: Sallie Mae's stock has dropped 20.1% over the past six months, now trading at $21.71 per share, prompting investors to reconsider their holdings in light of this significant decline.
- Lackluster Revenue Growth: With $1.96 billion in revenue over the trailing 12 months, Sallie Mae's performance is stagnant compared to five years ago, indicating a failure to consistently increase demand and reflecting poor business quality.
- Slow EPS Growth: The company's earnings per share (EPS) grew at a compounded annual growth rate of 3.1% over the last five years, which, while better than flat revenue, suggests management's response to weaker demand through cost structure adjustments.
- Cautious Investment Advice: Although Sallie Mae's forward P/E ratio stands at 8.1, making it appear cheap, the shaky fundamentals indicate significant downside risk, leading analysts to recommend focusing on more attractive stock options.
See More










